NAD+ levels decline significantly with age, chronic stress, and metabolic dysfunction
Current practice patterns extrapolated from animal studies and online communities typically involve subcutaneous injection of 0.25-0.5 mg once or twice daily, or oral administration of 0.5-1 mg daily to compensate for lower bioavailability
Before you reach for whats on the shelf, try shifting some of your habits first instead
Forcina, L., Miano, C., Scicchitano, B
Nobody is proposing injecting an entire vial at once, and the per-dose fractions are far smaller
You have existing cardiac rate issues: The heart rate elevation associated with retatrutide's glucagon component is a real reason to stick with a dual-agonist